Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Shannon, KM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Banerjee, A; Shannon, KM
      Leukemic transformation in patients with severe congenital neutropenia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    2. Shannon, KM; Le Beau, MM; Largaespada, DA; Killeen, N
      Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse

      SEMINARS IN CANCER BIOLOGY
    3. Kratz, CP; Emerling, BM; Donovan, S; Laig-Webster, M; Taylor, BR; Thompson, P; Jensen, S; Banerjee, A; Bonifas, J; Makalowski, W; Green, ED; Le Beau, MM; Shannon, KM
      Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies

      GENOMICS
    4. Lee, SB; Kim, SH; Bell, DW; Wahrer, DCR; Schiripo, TA; Jorczak, MM; Sgroi, DC; Garber, JE; Li, FP; Nichols, KE; Varley, JM; Godwin, AK; Shannon, KM; Harlow, E; Haber, DA
      Destabilization of CHK2 by a missense mutation associated with Li-Fraumenisyndrome

      CANCER RESEARCH
    5. Niendorf, KB; Shannon, KM
      The role of genetic testing and effect on patient care

      ARCHIVES OF DERMATOLOGY
    6. Flament, D; Shannon, KM; Neyman, I; Nicholas, JJ; Corcos, DM
      Impaired compensation for mechanical loads in a patient with hemiballismusfollowing stroke

      PARKINSONISM & RELATED DISORDERS
    7. Birnbaum, RA; O'Marcaigh, A; Wardak, Z; Zhang, YY; Dranoff, G; Jacks, T; Clapp, DW; Shannon, KM
      Nf1 and Gmcsf interact in myeloid leukemogenesis

      MOLECULAR CELL
    8. Miller, MS; Shannon, KM; Wetzel, GT
      Neonatal bradycardia

      PROGRESS IN PEDIATRIC CARDIOLOGY
    9. Cubo, E; Shannon, KM; Penn, RD; Kroin, JS
      Internal globus pallidotomy in dystonia secondary to Huntington's disease

      MOVEMENT DISORDERS
    10. Stebbins, GT; Gabrieli, JDE; Shannon, KM; Penn, RD; Goetz, CG
      Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease

      BRAIN AND COGNITION
    11. Cooper, LJN; Shannon, KM; Loken, MR; Weaver, M; Stephens, K; Sievers, EL
      Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell

      BLOOD
    12. Bennett, DA; Shannon, KM; Beckett, LA; Wilson, RS
      Dimensionality of parkinsonian signs in aging and Alzheimer's disease

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    13. Frucht, S; Fahn, S; Shannon, KM; Waters, CH
      A 32-year-old man with progressive spasticity and Parkinsonism

      MOVEMENT DISORDERS
    14. Mantadakis, E; Shannon, KM; Singer, DA; Finklestein, J; Chan, KW; Hilden, JM; Sandler, ES
      Transient monosomy 7 - A case series in children and review of the literature

      CANCER
    15. Mahgoub, N; Taylor, BR; Gratiot, M; Kohl, NE; Gibbs, JB; Jacks, T; Shannon, KM
      In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells

      BLOOD
    16. Luna-Fineman, S; Shannon, KM; Atwater, SK; Davis, J; Masterson, M; Ortega, J; Sanders, J; Steinherz, P; Weinberg, V; Lange, BJ
      Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients

      BLOOD
    17. Mahgoub, N; Taylor, BR; Le Beau, MM; Gratiot, M; Carlson, KM; Atwater, SK; Jacks, T; Shannon, KM
      Myeloid malignancies induced by alkylating agents in Nf1 mice

      BLOOD
    18. TORRES MB; SHANNON KM
      INFLUENCE OF DIFFERENT CELL ATTACHMENT SUBSTRATES ON SUCCESSFUL MICROINJECTION OF NEONATAL RABBIT VENTRICULAR MYOCYTES

      Journal of investigative medicine
    19. MAHGOUB N; PARKER RI; HOSLER MR; CLOSE P; WINICK NJ; MASTERSON M; SHANNON KM; FELIX CA
      RAS MUTATIONS IN PEDIATRIC LEUKEMIAS WITH MLL GENE REARRANGEMENTS

      Genes, chromosomes & cancer
    20. COMELLA CL; SHANNON KM; JAGLIN J
      EXTENSOR TRUNCAL DYSTONIA - SUCCESSFUL TREATMENT WITH BOTULINUM TOXININJECTIONS

      Movement disorders
    21. PFANN KD; PENN RD; SHANNON KM; CORCOS DM
      PALLIDOTOMY AND BRADYKINESIA - IMPLICATIONS FOR BASAL GANGLIA FUNCTION

      Neurology
    22. SHANNON KM; PENN RD; KROIN JS; ADLER CH; JANKO KA; YORK M; COX SJ
      STEREOTAXIC PALLIDOTOMY FOR THE TREATMENT OF PARKINSONS-DISEASE - EFFICACY AND ADVERSE-EFFECTS AT 6 MONTHS IN 26 PATIENTS

      Neurology
    23. FRENCK RW; BLACKBURN EH; SHANNON KM
      THE RATE OF TELOMERE SEQUENCE LOSS IN HUMAN-LEUKOCYTES VARIES WITH AGE

      Proceedings of the National Academy of Sciences of the United Statesof America
    24. REBOLLEDO MA; KROGSTAD P; CHEN FH; SHANNON KM; KLITZNER TS
      INFECTION OF HUMAN FETAL CARDIAC MYOCYTES BY A HUMAN IMMUNODEFICIENCYVIRUS-1-DERIVED VECTOR

      Circulation research
    25. SIDE LE; EMANUEL PD; TAYLOR B; FRANKLIN J; THOMPSON P; CASTLEBERRY RP; SHANNON KM
      MUTATIONS OF THE NF1 GENE IN CHILDREN WITH JUVENILE MYELOMONOCYTIC LEUKEMIA WITHOUT CLINICAL-EVIDENCE OF NEUROFIBROMATOSIS, TYPE-1

      Blood
    26. OMARCAIGH AS; SHANNON KM
      ROLE OF THE NF1 GENE IN LEUKEMOGENESIS AND MYELOID GROWTH-CONTROL

      Journal of pediatric hematology/oncology
    27. CHARLES PD; DAVIS TL; SHANNON KM; HOOK MA; WARNER JS
      TONGUE PROTRUSION DYSTONIA - TREATMENT WITH BOTULINUM TOXIN

      Southern medical journal
    28. SHANNON KM; WETZEL GT; MAGINOT KR; KLITZNER TS
      THE USE OF RADIOFREQUENCY ABLATION IN THE MANAGEMENT OF ARRHYTHMIA INPATIENTS WITH UNIVENTRICULAR HEART-DISEASE

      Pediatrics
    29. SHANNON KM; WETZEL GT; KNIGHT L; KLITZNER TS
      MANAGEMENT OF PATIENTS WITH TRICUSPID-ATRESIA AND AN ACCESSORY A-V CONNECTION

      Pediatrics
    30. BENNETT DA; SHANNON KM; BECKETT LA; GOETZ CG; WILSON RS
      METRIC PROPERTIES OF NURSES RATINGS OF PARKINSONIAN SIGNS WITH A MODIFIED UNIFIED PARKINSONS-DISEASE RATING-SCALE

      Neurology
    31. SHANNON KM; BENNETT JP; FRIEDMAN JH
      EFFICACY OF PRAMIPEXOLE, A NOVEL DOPAMINE AGONIST, AS MONOTHERAPY IN MILD-TO-MODERATE PARKINSONS-DISEASE

      Neurology
    32. STEBBINS GT; GABRIELI JDE; GOETZ CG; SHANNON KM; PENN RD; MASCIARI F
      IMPAIRED FRONTO-STRIATAL MEMORY FUNCTIONING FOLLOWING PALLIDOTOMY IN ADVANCED PARKINSONS-DISEASE

      Neurology
    33. SHANNON KM; PENN RD; KROIN JD; ADLER CH; JANKO KA; YORK M; COX SJ
      STEREOTAXIC PALLIDOTOMY FOR THE TREATMENT OF PARKINSONS-DISEASE - EFFICACY AND ADVERSE-EFFECTS AT 6 MONTHS IN 26 PATIENTS

      Neurology
    34. SIDE LE; SHANNON KM
      MYELOID DISORDERS IN INFANTS WITH NOONAN-SYNDROME AND A RESIDENTS RULE RECALLED

      The Journal of pediatrics
    35. SHANNON KM; REBOLLEDO MA; CHEN FH; KLITZNER TS; KROGSTAD P
      HUMAN FETAL CARDIAC MYOCYTES SUPPORT REPLICATION OF HIV RESULTING IN APOPTOSIS

      Circulation
    36. MARIS JM; WIERSMA SR; MAHGOUB N; THOMPSON P; GEYER RJ; HURWITZ CGH; LANGE BJ; SHANNON KM
      MONOSOMY-7 MYELODYSPLASTIC SYNDROME AND OTHER 2ND MALIGNANT NEOPLASMSIN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1

      Cancer
    37. MAHGOUB N; TAYLOR B; LEBEAU H; GRATIOT M; CARLSON K; JACKS T; SHANNON KM
      A MOUSE MODEL OF ALKYLATOR-INDUCED LEUKEMIA

      Blood
    38. BIRNBAUM R; OMARCAIGH A; WARDAK Z; ZHANG Y; DRANOFF G; JACKS T; CLAPP DW; SHANNON KM
      INTERACTION BETWEEN NF1 AND GMCSF IN LEUKEMOGENESIS AND HEMATOPOIETICENGRAFTMENT

      Blood
    39. SIDE LE; EMANUEL P; TAYLOR B; FRANKLIN J; THOMPSON P; CASTLEBERRY R; SHANNON KM
      MUTATIONS OF THE NF1 GENE IN LEUKEMIAS FROM CHILDREN WITHOUT EVIDENCEOF NEUROFIBROMATOSIS, TYPE-1

      Blood
    40. MAHGOUB N; TAYLOR B; GRATIOT M; KOHL N; GIBBS J; JACKS T; SHANNON KM
      EFFECTS OF FARNESYL TRANSFERASE INHIBITOR (FTI) L744, 832 IN A RAS-ACTIVATED MURINE MYELOID-LEUKEMIA MODEL

      Blood
    41. EMANUEL PD; SHANNON KM; CASTLEBERRY RP
      JUVENILE MYELOMONOCYTIC LEUKEMIA - MOLECULAR UNDERSTANDING AND PROSPECTS FOR THERAPY

      Molecular medicine today
    42. SHANNON KM
      CHOREA

      Current opinion in neurology
    43. MILES DK; FREEDMAN MH; PALLAVICINI M; SIEVERS E; THOMPSON T; SHANNON KM
      NEUROFIBROMATOSIS, TYPE-1 (NF1) AND CHILDHOOD LEUKEMIA - PARENT OF ORIGIN EFFECTS AND PATTERN OF ALLELIC LOSS AT THE NF1 LOCUS IN HEMATOPOIETIC-CELLS

      Journal of investigative medicine
    44. JANKO KA; SHANNON KM
      PARKINSONISM AND PARKINSONS-DISEASE

      Nurse practitioner forum
    45. SHANNON KM; KORDOWER JH
      NEURAL TRANSPLANTATION FOR HUNTINGTONS-DISEASE - EXPERIMENTAL RATIONALE AND RECOMMENDATIONS FOR CLINICAL-TRIALS

      Cell transplantation
    46. PFANN KD; PENN RD; SHANNON KM; SHAPIRO MB; CORCOS DM
      EFFECT OF STIMULATION IN THE VENTRAL INTERMEDIATE NUCLEUS OF THE THALAMUS ON LIMB CENTRAL IN PARKINSONS-DISEASE - A CASE-STUDY

      Movement disorders
    47. KIEBURTZ K; PENNEY JB; COMO P; RANEN N; SHOULSON I; FEIGIN A; ABWENDER D; GREENAMYRE JT; HIGGINS D; MARSHALL FJ; GOLDSTEIN J; STEINBERG K; SHIH C; RICHARD I; HICKEY C; ZIMMERMAN C; ORME C; CLAUDE K; OAKES D; SAX DS; KIM A; HERSCH S; JONES R; AUCHUS A; OLSEN D; BISSEYBLACK C; RUBIN A; SCHWARTZ R; DUBINSKY R; MALLONEE W; GRAY C; GODFREY N; SUTER G; SHANNON KM; STEBBINS GT; JAGLIN JA; MARDER K; TAYLOR S; LOUIS E; MOSKOWITZ C; THORNE D; ZUBIN N; WEXLER N; SWENSON MR; PAULSEN J; SWERDLOW N; ALBIN R; WERNETTE C; WALKER F; HUNT V; ROOS RAC; YOUNG AB; KOROSHETZ W; BIRD E; MEYERS R; CUDKOWICZ M; GUTTMAN M; STCYR J; BURKHOLDER J; LUNDIN A; ASHIZAWA T; JANKOVIC J; SIEMERS E; QUAID K; MARTIN W; SANCHEZRAMOS J; FACCA A; REY G; SUCHOWERSKY O; ROHS G; KLINEK ML; ROSS C; BYLSMA FW; SHERR M; HAYDEN M; RAYMOND L; CLARK C; KREMER B
      UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY

      Movement disorders
    48. BENNETT DA; BECKETT LA; MURRAY AM; SHANNON KM; GOETZ CG; PILGRIM DM; EVANS DA
      PREVALENCE OF PARKINSONIAN SIGNS AND ASSOCIATED MORTALITY IN A COMMUNITY POPULATION OF OLDER-PEOPLE

      The New England journal of medicine
    49. SHANNON KM; TRACY D; STEBBINS GT; COMELLA CL
      TIC SUPPRESSION IN GILLES-DE-LA-TOURETTE SYNDROME

      Neurology
    50. MILES DK; FREEDMAN MH; STEPHENS K; PALLAVICINI M; SIEVERS EL; WEAVER M; GRUNBERGER T; THOMPSON P; SHANNON KM
      PATTERNS OF HEMATOPOIETIC LINEAGE INVOLVEMENT IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND MALIGNANT MYELOID DISORDERS

      Blood
    51. BOLLAG G; ADLER F; ELMASRY N; MCCABE P; CONNOR E; THOMPSON P; MCCORMICK F; SHANNON KM
      CHARACTERIZATION OF A NOVEL INSERTIONAL KRAS MUTATION FROM A HUMAN MYELOID-LEUKEMIA

      Blood
    52. SIDE L; CAYOUETTE M; TAYLOR B; CONNOR E; THOMPSON P; LUCE M; SHANNON KM
      NEUROFIBROMATOSIS, TYPE-1 (NF1) GENE-MUTATIONS IN CHILDREN WITH NF1 AND MALIGNANT MYELOID DISORDERS

      Blood
    53. SIDE L; TEEL K; WANG P; MAHGOUB N; LARSON R; LEBEAU MM; SHANNON KM
      ACTIVATING RAS MUTATIONS IN THERAPY-RELATED MYELOID DISORDERS ASSOCIATED WITH DELETIONS OF CHROMOSOME-5 AND CHROMOSOME-7

      Blood
    54. THOMPSON P; LEBEAU MM; LARSON RA; GREEN ED; SHANNON KM
      ANALYSIS OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA (JCML) BONE MARROWSFOR SUBMICROSCOPIC DELETIONS ON 7Q

      Blood
    55. GUTMANN DH; GURNEY JG; SHANNON KM
      JUVENILE XANTHOGRANULOMA, NEUROFIBROMATOSIS-1, AND JUVENILE CHRONIC MYELOID-LEUKEMIA

      Archives of dermatology
    56. MENTZER WC; SHANNON KM
      THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PRETERM INFANTS

      International journal of pediatric hematology/oncology
    57. LINDHOLM KM; SHANNON KM; STEBBINS GT
      AXIAL AND LIMB APRAXIA IN PROGRESSIVE SUPRANUCLEAR PALSY

      Annals of neurology
    58. SHANNON KM; KEITH JF; MENTZER WC; EHRENKRANZ RA; BROWN MS; WIDNESS JA; GLEASON CA; BIFANO EM; MILLARD DD; DAVIS CB; STEVENSON DK; ALVERSON DC; SIMMONS CF; BRIM M; ABELS RI; PHIBBS RH
      RECOMBINANT-HUMAN-ERYTHROPOIETIN STIMULATES ERYTHROPOIESIS AND REDUCES ERYTHROCYTE TRANSFUSIONS IN VERY-LOW-BIRTH-WEIGHT PRETERM INFANTS

      Pediatrics
    59. SHANNON KM; KLITZNER TS; CHEN FH; VANDOP C
      EFFECTS OF TRIIODOTHYRONINE ON RETENTION OF BETA-ADRENERGIC RESPONSIVENESS OF VOLTAGE-GATED TRANSMEMBRANE CALCIUM CURRENT DURING CULTURE OFVENTRICULAR MYOCYTES FROM NEONATAL RABBITS

      Pediatric research
    60. MILES DK; FREEDMAN MH; STEPHENS K; PALLAVICINI M; SIEVERS E; LEPPIG K; GRUNBERGER T; THOMPSON P; SHANNON KM
      ALLELIC LOSS AT THE NF1 LOCUS AND HEMATOPOIETIC LINEAGE INVOLVEMENT IN MALIGNANT BONE MARROWS FROM CHILDREN WITH NEUROFIBROMATOSIS, TYPE-1 (NF1)

      Blood
    61. SIDE L; CAYOUETTE M; SHANNON KM; LUCE M
      MUTATIONAL ANALYSIS OF PATIENTS WITH NEUROFIBROMATOSIS, TYPE-1 (NF1) AND MALIGNANT MYELOID DISORDERS USING A PROTEIN TRUNCATION ASSAY

      Blood
    62. BOLLAG G; CLAPP DW; SHIH S; ADLER F; ZHANG Y; THOMPSON P; LANGE BJ; FREEDMAN MH; MCCORMICK F; JACKS T; SHANNON KM
      LOSS OF NF1 RESULTS IN ACTIVATION OF THE RAS SIGNALING PATHWAY AND LEADS TO ABERRANT GROWTH IN MURINE AND HUMAN HEMATOPOIETIC-CELLS

      Blood
    63. MAHGOUB N; FELIX CA; PARKER R; HOSLER M; SHANNON KM
      ACTIVATING RAS MUTATIONS ARE UNCOMMON IN LEUKEMIAS WITH 11Q23-TRANSLOCATIONS

      Blood
    64. LUNAFINEMAN S; SHANNON KM; LANGE BJ
      CHILDHOOD MONOSOMY-7 - EPIDEMIOLOGY, BIOLOGY, AND MECHANISTIC IMPLICATIONS

      Blood
    65. DRANT SE; KLITZNER TS; SHANNON KM; WETZEL GT; WILLIAMS RG
      GUIDANCE OF RADIOFREQUENCY CATHETER ABLATION BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN CHILDREN WITH PALLIATED SINGLE VENTRICLE

      The American journal of cardiology
    66. CHANG RKR; WETZEL GT; SHANNON KM; STEVENSON WG; KLITZNER TS
      AGE AND ANESTHESIA-RELATED CHANGES IN ACCESSORY PATHWAY CONDUCTION INCHILDREN WITH WOLFF-PARKINSON-WHITE SYNDROME

      The American journal of cardiology
    67. MATHUR VS; TOMLANOVICH SJ; SHANNON KM
      PRIMARY ERYTHROPOIETIC ABNORMALITY IN PATIENTS WITH POSTTRANSPLANT POLYCYTHEMIA (PTP) AND LOW SERUM ERYTHROPOIETIN (EPO) LEVELS

      Journal of the American Society of Nephrology
    68. SAVAGE P; FRENCK R; PADERANGA D; EMPEROR J; SHANNON KM
      PARENTAL ORIGINS OF CHROMOSOME-7 LOSS IN CHILDHOOD MONOSOMY-7 SYNDROME

      Leukemia
    69. COMELLA CL; STEBBINS GT; JANKO KA; SHANNON KM
      DIFFERENTIAL EFFECT OF DIRECT DOPAMINE AGONISTS ON THE MOTOR COMPONENTS OF PARKINSONS-DISEASE

      Annals of neurology
    70. KOLLER WC; BUSENBARK K; MINER K; ADAIR JC; AIGNER BR; ALBIN RI; ALEXANDER DN; ANTO CM; BENDER SE; BERG MJ; BERGIA BM; BLALOCK E; BURNS RS; COUCH JR; CRISOSTOMO EA; DAVIS LS; DAVIS TL; DIETRICH DW; DIMITSOPULOS TM; DOORENBOS D; ELLIS JR; ERTAG WD; FACTOR SA; FEIGIN AS; FREY KA; GADDIS KA; GIBSON GL; GOLDEN RE; GORDON MF; GREENAMYRE JT; GRIFFITH PA; GROTTA JC; HAUSER RA; HEIDEBRINK JL; HIGGINS DC; HILL SA; HILL TA; HUBBLE JP; HUTTON JT; JOHNSTON W; KIEBURTZ KD; KURLAN RM; LABUNETZ WH; LIEBERMAN AN; MAJUMDAR L; MARAGOS WF; MCCLOSKEY T; MCPHERSON SL; MILLER BR; NINO HE; OBRIEN CF; ONEILL A; OOMMEN KJ; OSBORN MA; PAHWA R; PAULSON GW; PODSKALNY GD; POOLE RM; PROTASS LM; PUGLIA JF; RICHFIELD EK; RILEY DE; SADEGHI H; SCHWARTZ H; SERANO RD; SHANNON KM; SHOULSON L; SHULMAN LM; SHULTS CW; SILVERSTEIN PM; SLEVIN JT; SNYDER RA; SOMERS AB; STACY M; SULLIVAN LP; VANHORN G; WEINER WJ; WEISS HD; WILLNER J; WILLIAMS MH; WONG GF; ZWIEBEL F
      THE RELATIONSHIP OF ESSENTIAL TREMOR TO OTHER MOVEMENT-DISORDERS - REPORT ON 678 PATIENTS

      Annals of neurology
    71. SHANNON KM; VANDOP C; CHEN FH; SCOTT ML; KLITZNER TS
      TRIIODOTHYRONINE AFFECTS BETA-ADRENERGIC RESPONSIVENESS OF CALCIUM CURRENTS IN CULTURED NEONATAL CARDIAC-CELLS

      Pediatric research
    72. SHANNON KM; OCONNELL P; MARTIN GA; PADERANGA D; OLSON K; DINNDORF P; MCCORMICK F
      LOSS OF THE NORMAL NF1 ALLELE FROM THE BONE-MARROW OF CHILDREN WITH TYPE-1 NEUROFIBROMATOSIS AND MALIGNANT MYELOID DISORDERS

      The New England journal of medicine
    73. BENNETT DA; BECKETT L; SHANNON KM; GOETZ CG; PILGRIM D; EVANS DA
      PREVALENCE OF PARKINSONISM IN A COMMUNITY POPULATION

      Neurology
    74. SHANNON KM; GOLDNER FS; COMELLA CL; GOETZ CG; STEBBINS GT
      DOPAMINERGIC PHARMACOLOGY OF BRADYKINESIA IN HUNTINGTONS-DISEASE (HD)

      Neurology
    75. KALRA R; PADERANGA DC; OLSON K; SHANNON KM
      GENETIC-ANALYSIS IS CONSISTENT WITH THE HYPOTHESIS THAT NF1 LIMITS MYELOID CELL-GROWTH THROUGH P21(RAS)

      Blood
    76. KAO JM; ALEJOS JC; GRANT PW; WILLIAMS RG; SHANNON KM; LAKS H
      CONVERSION OF ATRIOPULMONARY TO CAVOPULMONARY ANASTOMOSIS IN MANAGEMENT OF LATE ARRHYTHMIAS AND ATRIAL THROMBOSIS

      The Annals of thoracic surgery
    77. GOETZ CG; STEBBINS GT; THELEN JA; SHANNON KM; COMELLA CL
      TALIPEXOLE - SAFETY AND EFFICACY OF A DOPAMINE AUTOAGONIST IN GILLES-DE-LA-TOURETTES SYNDROME

      Annals of neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 02:06:52